|
Diabetes, Vol 40, Issue 4 478-481, Copyright © 1991 by American Diabetes Association
Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes
HA Erlich, RL Griffith, TL Bugawan, R Ziegler, C Alper and G Eisenbarth
Department of Human Genetics, Cetus Corporation, Emeryville, California 94608.
Genetic susceptibility to insulin-dependent diabetes mellitus (IDDM) is
associated with the HLA-DR3 and DR4 haplotypes. The HLA-DR2 haplotype is
negatively associated with IDDM, an association that has been interpreted
as dominant protection. Here, we describe the molecular analysis of the HLA
class II genes in an unusual family with three HLA-DR1/2 siblings, all of
whom have IDDM. With polymerase chain reaction amplification and sequence
analysis to characterize the class II alleles, we identified a novel DQB1
allele on the DR1 haplotype and an unusual DQB1 allele on the DR2
haplotype. However, the DRB1 alleles on these DR1 and DR2 haplotypes are
the conventional alleles (*0101 and *1501, respectively). These results
suggest that it is the conventional DQB1 allele (*0602) not the DRB1 allele
(*1501) on the protective DR2 haplotype that confers protection in the
general population and, furthermore, that these unusual DQB1 alleles may
confer susceptibility to IDDM in this family. The unusual DQB1 allele on
this DR2 haplotype encodes Asp at position 57, indicating that it is the
allele DQB1*0602 and not simply the presence of this residue that is
responsible for the protective effect.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. A. Al-Jenaidi, S. F. Wakim-Ghorayeb, A. Al-Abbasi, M. R. Arekat, N. Irani-Hakime, P. Najm, K. Al-Ola, A. A. Motala, and W. Y. Almawi
Contribution of Selective HLA-DRB1/DQB1 Alleles and Haplotypes to the Genetic Susceptibility of Type 1 Diabetes among Lebanese and Bahraini Arabs
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5104 - 5109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Al-Harbi, A.-J. Abbassi, H. Tamim, F. al-Jenaidi, M. Kooheji, M. Kamal, S. al-Mahroos, F. al-Nasir, A. A. Motala, and W. Y. Almawi
Specific HLA-DRB and -DQB Alleles and Haplotypes Confer Disease Susceptibility or Resistance in Bahraini Type 1 Diabetes Patients
Clin. Vaccine Immunol.,
March 1, 2004;
11(2):
292 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maldonado, C. S. Hampe, L. K. Gaur, S. D'Amico, D. Iyer, L. P. Hammerle, D. Bolgiano, L. Rodriguez, A. Rajan, A. Lernmark, et al.
Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and {beta}-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes
J. Clin. Endocrinol. Metab.,
November 1, 2003;
88(11):
5090 - 5098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schlosser, M. Strebelow, R. Wassmuth, M.-L. Arnold, I. Breunig, I. Rjasanowski, B. Ziegler, and M. Ziegler
The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of {beta}-Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive Individuals
J. Clin. Endocrinol. Metab.,
May 1, 2002;
87(5):
2254 - 2261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawabata, H. Ikegami, Y. Kawaguchi, T. Fujisawa, M. Shintani, M. Ono, M. Nishino, Y. Uchigata, I. Lee, and T. Ogihara
Asian-Specific HLA Haplotypes Reveal Heterogeneity of the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Type 1 Diabetes.
Diabetes,
February 1, 2002;
51(2):
545 - 551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Redondo, E. Kawasaki, C. L. Mulgrew, J. A. Noble, H. A. Erlich, B. M. Freed, B. A. Lie, E. Thorsby, G. S. Eisenbarth, D. E. Undlien, et al.
DR- and DQ-Associated Protection from Type 1A Diabetes: Comparison of DRB11401 and DQA10102-DQB10602
J. Clin. Endocrinol. Metab.,
October 1, 2000;
85(10):
3793 - 3797.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. J. Greenbaum, D. A. Schatz, D. Cuthbertson, A. Zeidler, G. S. Eisenbarth, and J. P. Krischer
Islet Cell Antibody-Positive Relatives with Human Leukocyte Antigen DQA10102, DQB10602: Identification by the Diabetes Prevention Trial-Type 1
J. Clin. Endocrinol. Metab.,
March 1, 2000;
85(3):
1255 - 1260.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Pugliese, E. Kawasaki, M. Zeller, L. Yu, S. Babu, M. Solimena, C. T. Moraes, M. Pietropaolo, R. P. Friday, M. Trucco, et al.
Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB10602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
May 1, 1999;
84(5):
1722 - 1728.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. H. Slover and G. S. Eisenbarth
Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets
Endocr. Rev.,
April 1, 1997;
18(2):
241 - 258.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1991 by the American Diabetes Association.
|
|
| |
|